VOYA Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,235
Closed -$536K 2973
2021
Q1
$536K Sell
14,235
-5,456
-28% -$136K ﹤0.01% 1991
2020
Q4
$335K Sell
19,691
-16,700
-46% -$209K ﹤0.01% 2141
2020
Q3
$171K Sell
36,391
-498
-1% -$2.53K ﹤0.01% 2204
2020
Q2
$225K Buy
36,889
+17,767
+93% +$73.2K ﹤0.01% 2102
2020
Q1
$43K Hold
19,122
﹤0.01% 2515
2019
Q4
$88K Buy
19,122
+4,992
+35% +$19.8K ﹤0.01% 2576
2019
Q3
$55K Hold
14,130
﹤0.01% 2494
2019
Q2
$85K Hold
14,130
﹤0.01% 2498
2019
Q1
$189K Hold
14,130
﹤0.01% 2284
2018
Q4
$131K Hold
14,130
﹤0.01% 2345
2018
Q3
$197K Hold
14,130
﹤0.01% 2341
2018
Q2
$223K Buy
14,130
+1,536
+12% +$26.8K ﹤0.01% 2315
2018
Q1
$216K Hold
12,594
﹤0.01% 2282
2017
Q4
$276K Hold
12,594
﹤0.01% 2186
2017
Q3
$515K Hold
12,594
﹤0.01% 1862
2017
Q2
$379K Buy
12,594
+1,097
+10% +$34.2K ﹤0.01% 2009
2017
Q1
$416K Hold
11,497
﹤0.01% 1827
2016
Q4
$576K Hold
11,497
﹤0.01% 1654
2016
Q3
$603 Hold
11,497
﹤0.01% 1626
2016
Q2
$475K Buy
11,497
+1,835
+19% +$79.8K ﹤0.01% 1752
2016
Q1
$393K Hold
9,662
﹤0.01% 1844
2015
Q4
$401K Buy
+9,662
New +$324K ﹤0.01% 1863
2015
Q3
Sell
-12,705
Closed -$316K 2614
2015
Q2
$316K Hold
12,705
﹤0.01% 2228
2015
Q1
$290K Hold
12,705
﹤0.01% 2244
2014
Q4
$343K Hold
12,705
﹤0.01% 2181
2014
Q3
$149K Hold
12,705
﹤0.01% 2560
2014
Q2
$198K Buy
+12,705
New +$182K ﹤0.01% 2566

VOYA Investment Management's FPRX Position: Q2 2021 in Review

VOYA Investment Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 14,235 shares — an estimated $536K sold.

VOYA Investment Management first reported a position in FPRX in Q2 2014 and held it in 27 quarters. The position peaked at $576K in Q4 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • VOYA Investment Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 14,235 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $536K.
  • VOYA Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q2 2014 and held it in 27 quarters.
  • VOYA Investment Management's Five Prime Therapeutics, Inc. position peaked at $576K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.